Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (4 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (8)
Guidance programme
(
1 selected
)
Guidance programme
Technology appraisal guidance (8)
Apply filters
Showing 1 to 8 of 8
Sort by
Date
Title
Apply sorting
lung cancer
Remove lung cancer filter
Last updated date between 1/4/2016 and 30/4/2017
Remove Last updated date between 1/4/2016 and 30/4/2017 filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell
lung cancer
(terminated appraisal)
TA438
29 March 2017
29 March 2017
Bevacizumab for treating EGFR mutation-positive non-small-cell
lung cancer
(terminated appraisal)
TA436
22 March 2017
22 March 2017
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell
lung cancer
TA422
21 December 2016
21 December 2016
Necitumumab for untreated advanced or metastatic squamous non-small-cell
lung cancer
TA411
28 September 2016
28 September 2016
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell
lung cancer
TA406
28 September 2016
28 September 2016
Pemetrexed maintenance treatment for non-squamous non-small-cell
lung cancer
after pemetrexed and cisplatin
TA402
24 August 2016
24 August 2016
Ramucirumab for previously treated locally advanced or metastatic non-small-cell
lung cancer
TA403
24 August 2016
24 August 2016
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell
lung cancer
TA395
22 June 2016
22 June 2016
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top